TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.

John Koreth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.